Literature DB >> 32402156

Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.

Meghan E Sise1, Meridale V Baggett1, Jo-Anne O Shepard1, Jacob S Stevens1, Eugene P Rhee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32402156      PMCID： PMC7959270          DOI： 10.1056/NEJMcpc2002418

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Intensity of continuous renal-replacement therapy in critically ill patients.

Authors:  Rinaldo Bellomo; Alan Cass; Louise Cole; Simon Finfer; Martin Gallagher; Serigne Lo; Colin McArthur; Shay McGuinness; John Myburgh; Robyn Norton; Carlos Scheinkestel; Steve Su
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].

Authors: 
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2020-03-12

4.  Renal ACE2 expression in human kidney disease.

Authors:  A T Lely; I Hamming; H van Goor; G J Navis
Journal:  J Pathol       Date:  2004-12       Impact factor: 7.996

5.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

Review 6.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

7.  Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.

Authors:  Hua Su; Ming Yang; Cheng Wan; Li-Xia Yi; Fang Tang; Hong-Yan Zhu; Fan Yi; Hai-Chun Yang; Agnes B Fogo; Xiu Nie; Chun Zhang
Journal:  Kidney Int       Date:  2020-04-09       Impact factor: 10.612

8.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

Authors:  Manli Wang; Ruiyuan Cao; Leike Zhang; Xinglou Yang; Jia Liu; Mingyue Xu; Zhengli Shi; Zhihong Hu; Wu Zhong; Gengfu Xiao
Journal:  Cell Res       Date:  2020-02-04       Impact factor: 25.617

9.  [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Authors:  Jun Chen; Danping Liu; Li Liu; Ping Liu; Qingnian Xu; Lu Xia; Yun Ling; Dan Huang; Shuli Song; Dandan Zhang; Zhiping Qian; Tao Li; Yinzhong Shen; Hongzhou Lu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

10.  Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.

Authors:  Jia Liu; Ruiyuan Cao; Mingyue Xu; Xi Wang; Huanyu Zhang; Hengrui Hu; Yufeng Li; Zhihong Hu; Wu Zhong; Manli Wang
Journal:  Cell Discov       Date:  2020-03-18       Impact factor: 10.849
View more
  32 in total

1.  Kidney Biopsy Findings in Patients with COVID-19.

Authors:  Satoru Kudose; Ibrahim Batal; Dominick Santoriello; Katherine Xu; Jonathan Barasch; Yonatan Peleg; Pietro Canetta; Lloyd E Ratner; Maddalena Marasa; Ali G Gharavi; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2020-07-17       Impact factor: 10.121

2.  CKRT Clotting and Cerebrovascular Accident in a Critically Ill Patient.

Authors:  Carmen Elena Cervantes; Steven Menez; Mohamad Hanouneh
Journal:  Kidney360       Date:  2020-07-20

3.  Dialysis Filter Life in COVID-19: Early Lessons from the Pandemic.

Authors:  Ignacio Portales-Castillo; Andrew S Allegretti
Journal:  Kidney360       Date:  2020-12-31

4.  COVID-19 presenting with myocardial infarction with nonobstructive coronary arteries.

Authors:  Mahmoud Ismayl; Dua Noor Butt; Akshay Machanahalli Balakrishna; Omar Kousa; Amjad Kabach
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-08

Review 5.  Potential role of biochemical markers in the prognosis of COVID-19 patients.

Authors:  Apeksha Niraula; Nirmal Baral; Madhab Lamsal; Mahima Bataju; Saroj Thapa
Journal:  SAGE Open Med       Date:  2022-07-05

6.  Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.

Authors:  Divya Shankaranarayanan; Thangamani Muthukumar; Tarek Barbar; Aarti Bhasin; Supriya Gerardine; Perola Lamba; Lorenz Leuprecht; Sanjay P Neupane; Thalia Salinas; Daniil Shimonov; Elly Varma; Frank Liu
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-17       Impact factor: 8.237

Review 7.  Mass Disasters and Burnout in Nephrology Personnel: From Earthquakes and Hurricanes to COVID-19 Pandemic.

Authors:  Mehmet Sukru Sever; Alberto Ortiz; Umberto Maggiore; Enrique Bac-García; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-07       Impact factor: 8.237

Review 8.  Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis.

Authors:  Jun Tao; Rebecca Aristotelidis; Alexandra Zanowick-Marr; Laura C Chambers; James McDonald; Eleftherios E Mylonakis; Philip A Chan
Journal:  SN Compr Clin Med       Date:  2021-08-07

9.  Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis.

Authors:  Hadeel Alkofide; Abdullah Almohaizeie; Sara Almuhaini; Bashayer Alotaibi; Khalid M Alkharfy
Journal:  Int J Infect Dis       Date:  2021-07-14       Impact factor: 3.623

10.  Lower urinary tract signs and symptoms in patients with COVID-19.

Authors:  Aida Javan Balegh Marand; Christian Bach; Dick Janssen; John Heesakkers; Morteza Ghojazadeh; Thomas Alexander Vögeli; Hanieh Salehi-Pourmehr; Hadi Mostafae; Sakineh Hajebrahimi; Mohammad Sajjad Rahnama'i
Journal:  BMC Infect Dis       Date:  2021-07-26       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.